Literature DB >> 21642621

Expression of PDGFRα is a determinant of the PVR potential of ARPE19 cells.

Hetian Lei1, Marc-André Rhéaume, Gisela Velez, Shizuo Mukai, Andrius Kazlauskas.   

Abstract

PURPOSE: Previous studies indicate that the expression of platelet-derived growth factor (PDGF) receptor α (PDGFRα) dramatically increases the ability of fibroblasts to induce experimental proliferative vitreoretinopathy (PVR). The purpose of this study was to determine whether PDGFRα contributed to the PVR potential of retinal pigment epithelial (RPE) cells, one of the most abundant cell types in PVR membranes.
METHODS: PDGFRα expression in human ARPE19 cells was increased or decreased by stably expressing the PDGFRα cDNA or short hairpin (sh) RNA directed at PDGFRα, respectively. The level of PDGFRα expression in the resulting panel of cell lines was either barely detectable (KD), standard (similar to the level of primary RPE cells), or overexpressed approximately 80-fold. Western blot analysis was used to assess the level of p53 and the activation state of PDGFRα and Akt. The following cellular responses were monitored: proliferation, apoptosis, and contraction. The PVR potential of cells was tested in a rabbit model of PVR in which cells were coinjected with platelet-rich plasma into the vitreous.
RESULTS: Comparison of KD and overexpressing cells indicated that high-level expression of PDGFRα dramatically augmented signaling events, cellular responses, and the PVR potential of ARPE19 cells. However, all these outcomes were also significantly increased, albeit not as robustly, by PDGFRα expression to the level typically present in RPE cells.
CONCLUSIONS: Even though RPE cells express substantially less PDGFRα than fibroblasts, it significantly boosts PVR-related signaling events, cellular responses, and the PVR potential of ARPE19 cells. These studies suggest that inhibiting activation, signaling, or both by PDGFRα has the potential to prevent the development of PVR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21642621      PMCID: PMC3176061          DOI: 10.1167/iovs.11-7442

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  28 in total

1.  Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes.

Authors:  S A Vinores; P A Campochiaro; B P Conway
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-01       Impact factor: 4.799

Review 2.  Traction retinal detachment. XLIX Edward Jackson Memorial Lecture.

Authors:  S J Ryan
Journal:  Am J Ophthalmol       Date:  1993-01       Impact factor: 5.258

3.  Experimental intraocular proliferation and neovascularization.

Authors:  A Ophir; M S Blumenkranz; A J Claflin
Journal:  Am J Ophthalmol       Date:  1982-10       Impact factor: 5.258

4.  Retinoic acid in silicone and silicone-fluorosilicone copolymer oils in a rabbit model of proliferative vitreoretinopathy.

Authors:  M Nakagawa; M F Refojo; J F Marin; M Doi; F I Tolentino
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-11       Impact factor: 4.799

5.  Platelet-derived growth factor receptor kinase inhibitor AG1295 and inhibition of experimental proliferative vitreoretinopathy.

Authors:  Yuping Zheng; Yasushi Ikuno; Masahito Ohj; Shunji Kusaka; Rui Jiang; Osman Cekiç; Miki Sawa; Yasuo Tano
Journal:  Jpn J Ophthalmol       Date:  2003 Mar-Apr       Impact factor: 2.447

6.  Proliferative vitreoretinopathy membranes. An immunohistochemical study.

Authors:  J A Jerdan; J S Pepose; R G Michels; H Hayashi; S de Bustros; M Sebag; B M Glaser
Journal:  Ophthalmology       Date:  1989-06       Impact factor: 12.079

7.  Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.

Authors:  S G Robbins; R N Mixon; D J Wilson; C E Hart; J E Robertson; I Westra; S R Planck; J T Rosenbaum
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-09       Impact factor: 4.799

8.  Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy.

Authors:  C Baudouin; D Fredj-Reygrobellet; F Brignole; F Nègre; P Lapalus; P Gastaud
Journal:  Ophthalmic Res       Date:  1993       Impact factor: 2.892

9.  Induction of proliferative vitreoretinopathy by a unique line of human retinal pigment epithelial cells.

Authors:  Christian A Wong; Michael J Potter; Jing Z Cui; Tom S Chang; Patrick Ma; Alan L Maberley; William H Ross; Valerie A White; Arif Samad; William Jia; Dan Hornan; Joanne A Matsubara
Journal:  Can J Ophthalmol       Date:  2002-06       Impact factor: 1.882

10.  Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells.

Authors:  P A Campochiaro; S F Hackett; S A Vinores; J Freund; C Csaky; W LaRochelle; J Henderer; M Johnson; I R Rodriguez; Z Friedman
Journal:  J Cell Sci       Date:  1994-09       Impact factor: 5.285

View more
  22 in total

Review 1.  Primary Cilia and Coordination of Receptor Tyrosine Kinase (RTK) and Transforming Growth Factor β (TGF-β) Signaling.

Authors:  Søren T Christensen; Stine K Morthorst; Johanne B Mogensen; Lotte B Pedersen
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-06-01       Impact factor: 10.005

2.  Vascular endothelial growth factor acts primarily via platelet-derived growth factor receptor α to promote proliferative vitreoretinopathy.

Authors:  Steven Pennock; Luis J Haddock; Shizuo Mukai; Andrius Kazlauskas
Journal:  Am J Pathol       Date:  2014-09-26       Impact factor: 4.307

3.  RasGAP Promotes Autophagy and Thereby Suppresses Platelet-Derived Growth Factor Receptor-Mediated Signaling Events, Cellular Responses, and Pathology.

Authors:  Hetian Lei; Cynthia X Qian; Jinghu Lei; Luis J Haddock; Shizuo Mukai; Andrius Kazlauskas
Journal:  Mol Cell Biol       Date:  2015-03-02       Impact factor: 4.272

4.  The Human Cytomegalovirus Trimer and Pentamer Promote Sequential Steps in Entry into Epithelial and Endothelial Cells at Cell Surfaces and Endosomes.

Authors:  Jing Liu; Ted S Jardetzky; Andrea L Chin; David C Johnson; Adam L Vanarsdall
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

5.  Phosphoinositide 3-kinase δ inactivation prevents vitreous-induced activation of AKT/MDM2/p53 and migration of retinal pigment epithelial cells.

Authors:  Haote Han; Na Chen; Xionggao Huang; Bing Liu; Jingkui Tian; Hetian Lei
Journal:  J Biol Chem       Date:  2019-08-29       Impact factor: 5.157

Review 6.  Genome-wide association studies: applications and insights gained in Ophthalmology.

Authors:  A Chandra; D Mitry; A Wright; H Campbell; D G Charteris
Journal:  Eye (Lond)       Date:  2014-06-27       Impact factor: 3.775

7.  Vascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responses.

Authors:  Steven Pennock; Andrius Kazlauskas
Journal:  Mol Cell Biol       Date:  2012-03-19       Impact factor: 4.272

8.  Vascular Endothelial Cell Growth Factor A Acts via Platelet-Derived Growth Factor Receptor α To Promote Viability of Cells Enduring Hypoxia.

Authors:  Steven Pennock; Leo A Kim; Andrius Kazlauskas
Journal:  Mol Cell Biol       Date:  2016-08-26       Impact factor: 4.272

Review 9.  Proliferative Vitreoretinopathy: A Review.

Authors:  Sana Idrees; Jayanth Sridhar; Ajay E Kuriyan
Journal:  Int Ophthalmol Clin       Date:  2019

10.  A reactive oxygen species-mediated, self-perpetuating loop persistently activates platelet-derived growth factor receptor α.

Authors:  Hetian Lei; Andrius Kazlauskas
Journal:  Mol Cell Biol       Date:  2013-11-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.